LncRNA MYO16-AS1 and MICAL2 axis sustains proliferation and migration in ovarian cancer cells and unveils a therapeutic vulnerability in patient-derived tumor organoids
Mohammad Ahmad, L. Thorel, E. Brotin, E. Abeilard, M. N'Diaye, Shéhérazade Sebda, Jean-Pascal Meneboo, Martin Figeac, B. Bernay, L. Poulain, L. B. Weiswald, C. Denoyelle, Matthieu Meryet-Figuière
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.